Amber Therapeutics is a startup based in the United Kingdom, most recent round Series A, 1 tracked investor.
Amber Therapeutics is a company founded in 2021 headquartered in the United Kingdom. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Amber Therapeutics develops the first fully implantable adaptive neuromodulation therapy for mixed urinary incontinence, targeting the pudendal nerve through a minimally invasive procedure to restore normal bladder function in women.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.